| 生物活性 |
Favezelimab (MK-4280) is a humanized monoclonal antibody targeting LAG-3. Favezelimab blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research in combination with the PD-L1 inhibitor Pembrolizumab . Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control .
|
|---|---|
| 分子量 |
145.98 kDa
|
| CAS号 |
2231068-83-8
|
| 运输条件 |
Shipping with dry ice.
|
| 储存方式 |
Store at -20˚C
|
纯度： 97%
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet